Giuseppe Fracchiolla

Prof. Dr. Giuseppe Fracchiolla

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2007 in Journal of Biological Chemistry
Verified
Journal Article
Open access
GPGiorgio Pochetti
Giorgio Pochetti
CGCristina Godio
Cristina Godio
NMNico Mitro
Nico Mitro
DCDonatella Caruso
Donatella Caruso
AGAndrea Galmozzi
Andrea Galmozzi
Maurizio CrestaniMaurizio Crestani
Maurizio Crestani
The peroxisome proliferator-activated receptors (PPARs) are transcriptional regulators of glucose and lipid metabolism. They are activated by natural ligands, such as fatty acids, and are also targets of synthetic antidiabetic and hypolipidemic drugs. By using cell-based reporter assays, we studied the transactivation activity of two enantiomeric ureidofibrate-like derivatives. In particular, we show that the R-enantiomer, (R)-1, is a full agonist of PPARgamma, whereas the S-enantiomer, (S)-1, is a less potent partial agonist. Most importantly, we report the x-ray crystal structures of the PPARgamma ligand binding domain complexed with the R- and the S-enantiomer, respectively. The analysis of the two crystal structures shows that the different degree of stabilization of the helix 12 induced by the ligand determines its behavior as full or partial agonist. Another crystal structure of the PPARgamma.(S)-1 complex, only differing in the soaking time of the ligand, is also presented. The comparison of the two structures of the complexes with the partial agonist reveals significant differences and is suggestive of the possible coexistence in solution of transcriptionally active and inactive forms of helix 12 in the presence of a partial agonist. Mutation analysis confirms the importance of Leu(465), Leu(469), and Ile(472) in the activation by (R)-1 and underscores the key role of Gln(286) in the PPARgamma activity.

18 November 2008 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
RMRoberta Montanari
Roberta Montanari
FSFulvio Saccoccia
Fulvio Saccoccia
ESElena Scotti
Elena Scotti
Maurizio CrestaniMaurizio Crestani
Maurizio Crestani
CGCristina Godio
Cristina Godio
GPGiorgio Pochetti
Giorgio Pochetti

20 July 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
MGMichela Galgano
Michela Galgano
PCPaolo Capozza
Paolo Capozza
FPFrancesco Pellegrini
Francesco Pellegrini
MCMarco Cordisco
Marco Cordisco
ASAlessio Sposato
Alessio Sposato
Annamaria PratelliAnnamaria Pratelli
Annamaria Pratelli
The spread of extended-spectrum β-lactamase-producing Escherichia coli and methicillin-resistant Staphylococcus aureus has caused a reduction in antibiotic effectiveness and an increase in mortality rates. Essential oils (EOs), known for their therapeutic efficacy, can be configured as novel broad-spectrum biocides. Accordingly, the bacteriostatic–bactericidal activity of Citrus Lemon (LEO), Pinus Sylvestris (PEO), Foeniculum Vulgaris (FEO), Ocimum Basilicum (BEO), Melissa Officinalis (MEO), Thymus Vulgaris (TEO), and Zingiber Officinalis Rosc. (GEO), at concentrations ranging from 1.25 to 40% (v/v), were tested in vitro against different E. coli and S. aureus strains using minimal inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs). The chemical compositions of the EOs were analyzed using GC/MS. The major components of all seven tested oils were limonene, α-pinene, anethole, estragole, citral, thymol, and zingiberene, respectively. We found that the bacteriostatic–bactericidal activity of the EOs was related to their chemotypes and concentrations, as well as the strain of the bacteria. A dose–effect correlation was found when testing GEO against S. aureus strains, whilst FEO was found to have no activity regardless of concentration. PEO, MEO, and BEO were found to have bactericidal effect with a MIC and MBC of 1.25% (v/v) against S. aureus strains, and LEO was found to have values of 1.25% (v/v) and 5% (v/v) against ATCC and clinical isolate, respectively. Interestingly, the antimicrobial activity of TEO was not related to oil concentration and the complete inhibition of growth across all E. coli and S. aureus was observed. Although preliminary, our data demonstrate the efficacy of EOs and pave the way for further investigations on their potential synergistic use with traditional drugs in the human and veterinary fields.

8 December 2023 in Antioxidants
Verified
Journal Article
Open access
PDF file
GMGiovanni Martemucci
Giovanni Martemucci
GFGiuseppe Fracchiolla
Giuseppe Fracchiolla
MARILENA MURAGLIAMARILENA MURAGLIA
MARILENA MURAGLIA
Roberta TardugnoRoberta Tardugno
Roberta Tardugno
RDRoberta Savina Dibenedetto
Roberta Savina Dibenedetto
ADA.G. D'Alessandro
A.G. D'Alessandro
Metabolic syndrome (MS) is a growing disorder affecting thousands of people worldwide, especially in industrialised countries, increasing mortality. Oxidative stress, hyperglycaemia, insulin resistance, inflammation, dysbiosis, abdominal obesity, atherogenic dyslipidaemia and hypertension are important factors linked to MS clusters of different pathologies, such as diabesity, cardiovascular diseases and neurological disorders. All biochemical changes observed in MS, such as dysregulation in the glucose and lipid metabolism, immune response, endothelial cell function and intestinal microbiota, promote pathological bridges between metabolic syndrome, diabesity and cardiovascular and neurodegenerative disorders. This review aims to summarise metabolic syndrome’s involvement in diabesity and highlight the link between MS and cardiovascular and neurological diseases. A better understanding of MS could promote a novel strategic approach to reduce MS comorbidities.

1 August 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ARAntonio Rosato
Antonio Rosato
ACAlessia Carocci
Alessia Carocci
ACAlessia Catalano
Alessia Catalano
MCMaria Lisa Clodoveo
Maria Lisa Clodoveo
CFCarlo Franchini
Carlo Franchini
GFGiuseppe Fracchiolla
Giuseppe Fracchiolla
Mentha piperita L. essential oil (EO) is employed for external use as antipruritic, astringent, rubefacient and antiseptic. Several studies demonstrated its significant antiviral, antifungal and antibacterial properties. The aim of this work is the study of the synergistic effects of M. piperita EO with antibacterials and antifungals that are widely available and currently prescribed in therapies against infections. The observed strong synergy may constitute a potential new approach to counter the increasing phenomenon of multidrug resistant bacteria and fungi. In vitro efficacy of the association M. piperita EO/drugs was evaluated against a large panel of Gram-positive and Gram-negative bacteria and yeast strains. The antimicrobial effects were studied by checkerboard microdilution method. The synergistic effect of M. piperita EO with gentamicin resulted in a strong growth inhibition for all the bacterial species under study. The synergistic effect observed for M. piperita EO and antifungals was less pronounced.

24 September 2020 in Antibiotics
Verified
Journal Article
Open access
PDF file
ARAntonio Rosato
Antonio Rosato
Sabina SblanoSabina Sblano
Sabina Sblano
Lara SalvagnoLara Salvagno
Lara Salvagno
ACAlessia Carocci
Alessia Carocci
maria clodoveomaria clodoveo
maria clodoveo
GFGiuseppe Fracchiolla
Giuseppe Fracchiolla
In recent years, the increase of bacteria antibiotic- resistance has been a severe problem for public health. A useful solution could be to join some phytochemicals naturally present in essential oils (EOs) to the existing antibiotics, with the aim to increase their efficacy in therapies. According to in vitro studies, EOs and their components could show such effects. Among them, we studied the activity of Cinnammonum zeylanicum, Mentha piperita, Origanum vulgare, and Thymus vulgaris EOs on bacterial biofilm and their synergism when used in association with some common antibiotics such as norfloxacin, oxacillin, and gentamicin. The chemical composition of EOs was determined using gas chromatography (GC) coupled with mass spectrometry (MS) techniques. The EOs drug efficacy was evaluated on four different strains of Gram-positive bacteria forming biofilms. The synergistic effects were tested through the chequerboard microdilution method. The association EOs-antibiotics showed a strong destruction of the biofilm growth of the four bacterial species considered. The interaction of norfloxacin with EOs was the most effective in all the tested combinations against the strains object of this study. These preliminary results suggest the formulation of a new generation of antimicrobial agents based on a combination of antimicrobial compounds with different origin.